InVitroLogics ApS: Financial statements 2024
CVR: 34044562
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
InVitroLogics ApS (CVR 34044562) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,326 and a net result of DKK -1,327 compared with DKK -15,211 the year before. Equity in the 2024 report amounted to DKK -330,513.
- Gross Profit
- DKK -1,326
- Profit/Loss
- DKK -1,327
- Equity
- DKK -330,513
- Total Assets
- DKK 10,984
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1 t. | -1 t. | -331 t. | - |
| 2023 | - | -15 t. | -15 t. | -411 t. | - |
| 2022 | - | -64 t. | -76 t. | -395 t. | 0 |
| 2021 | 48 t. | 48 t. | 37 t. | -319 t. | - |
| 2020 | - | -41 t. | -41 t. | -356 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
InVitroLogics ApS has published its annual report for 2023. Gross profit came to DKK -15,211, and the net result was DKK -15,211.
About InVitroLogics ApS
InVitroLogics ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2011. The company is registered under the industry Detailhandel med andre medicinske og ortopædiske artikler. The management consists of Claus Pedersen Blicher. The company is owned by ADZUKI HOLDING ApS. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,448 and a net result of DKK -2,448 compared with DKK -1,327 the year before. Equity in the 2025 report amounted to DKK -333,763.